Live Breaking News & Updates on Peter Maag|Page 16

Stay updated with breaking news from Peter maag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Anti-CD19 CAR T-Cell Therapy Fast Tracked for Lupus Nephritis

The FDA has granted Fast Track designation to KYV-101 for the treatment of patients with refractory lupus nephritis. ....

Peter Maag , Drug Administration , Fast Track ,

Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in Lupus Nephritis

/PRNewswire/ Kyverna Therapeutics ("Kyverna"), a cell therapy company with the mission of engineering a new class of therapies for serious autoimmune. ....

Paul Ehrlich Institut , Peter Maag , National Institutes Of Health , European Union Eu Clinical Trial Application , Drug Administration , Fast Track , European Union , Clinical Trial Application , Accelerated Approval , Priority Review , Lupus Nephritis , National Institutes , Nature Reviews Rheumatology , Chronic Kidney , Nature Medicine , Kyverna Therapeutics ,

Kyverna Therapeutics to Present New Data of KYV-101 in Lupus at European Congress of Rheumatology

Kyverna Therapeutics to Present New Data of KYV-101 in Lupus at European Congress of Rheumatology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Georg Schett , David Jayne , Petera Merkel , Dominic Borie , Peter Maag , University Hospital Erlangen , Friedrich Alexander University , University Of Erlangen , European Congress , National Institutes Of Health , University Of Pennsylvania , Lupus Service , Centre De , Fully Human , Autoimmune Patient Lymphocytes , Cell Therapy , B Cell Driven Autoimmune , Des Maladies Auto Immunes Syst , Lupus Nephritis , National Institutes , Nature Reviews Rheumatology , Chronic Kidney , Nature Medicine ,

102,232 Shares in CareDx, Inc (NASDAQ:CDNA) Bought by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC purchased a new position in shares of CareDx, Inc (NASDAQ:CDNA – Get Rating) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 102,232 shares of the company’s stock, valued at approximately $1,166,000. Several other institutional investors and hedge […] ....

Los Angeles , United States , Hong Kong , Zurcher Kantonalbank Zurich Cantonalbank , Craig Hallum , Raymond James , Peter Maag , Securities Exchange Commission , Los Angeles Capital Management , Hong Kong Ltd , Goldman Sachs Group , Caredx Inc , Lazard Asset Management , Exchange Commission , Get Rating , Kantonalbank Zurich Cantonalbank , Asset Management , Kong Ltd , Reginald Seeto , Director Peter Maag , Visit Holdingschannel , Caredx Daily , Nasdaq Cdna , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

CareDx, Inc (NASDAQ:CDNA) Receives Average Rating of "Hold" from Analysts

CareDx, Inc (NASDAQ:CDNA – Get Rating) has been given an average rating of “Hold” by the six ratings firms that are currently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year target price […] ....

Craig Hallum , Peter Maag , Caredx Inc , Goldman Sachs Group , Us Bancorp , Caredx Company Profile , Alphacrest Capital Management , Cetera Advisor Networks , Metlife Investment Management , Get Rating , Marketbeat Ratings , Reginald Seeto , Director Peter Maag , Advisor Networks , Crest Capital Management , Life Investment Management , Rhumbline Advisers , Caredx Daily , Nasdaq Cdna ,